Prolotherapy
Prolotherapy ("Proliferative Injection Therapy") involves injecting an otherwise non-pharmacological and non-active irritant solution into the body, generally in the region of tendons or ligaments for the purpose of strengthening weakened connective tissue and alleviating musculoskeletal pain.[1] Prolotherapy is also known as "proliferation therapy" or "regenerative injection therapy."
As of April 2005, doctors at the Mayo Clinic began supporting prolotherapy. Robert D. Sheeler, MD (Medical Editor, Mayo Clinic Health letter) first learned of prolotherapy through C. Everett Koop’s interest in the treatment. Mayo Clinic doctors list the areas that are most likely to benefit from prolotherapy treatment: ankles, knees, elbows, and the sacroiliac joint located in the lower back. They report that "unlike corticosteroid injections — which may provide temporary relief — prolotherapy involves improving the injected tissue by stimulating tissue growth."[2]
Contents
History
Injections of irritant solutions were performed in the late 1800’s to repair hernias and in the early 1900’s for jaw pain due to temporomandibular (jaw) joint laxity. George S. Hackett developed the technique of prolotherapy in the 1940’s. Gustav Hemwall was a pioneer, beginning his studies and treatments in the 1950s and continuing until the mid 1990s. In his study of almost 10,000 prolotherapy cases, Dr. Hackett found that over 99 percent of the patients found relief from their chronic pain.[3]
Prolotherapy in clinical practice
Prolotherapy involves the injection of an irritant solution into the area where connective tissue has been weakened or damaged through injury or strain. Many solutions are used, including dextrose, lidocaine (a commonly used local anesthetic), phenol, glycerine, or cod liver oil extract. The injection is given into joint capsules or where tendon connects to bone. Many points may require injection. The Injected solution causes the body to heal itself through the process of inflammation and repair. In the case of weakened or torn connective tissue, induced inflammation and release of growth factor at the site of injury may result in a 30-40% strengthening of the attachment points, although strong scientific evidence supporting this is lacking.
Prolotherapy treatment sessions are generally given every two to six weeks. Many patients receive treatment at less and less frequent intervals until treatments are required only every several years, if at all.[4]
Allen R Banks, Ph.D., has described in detail the theory behind prolotherapy in "A Rationale for Prolotherapy".[4]
Guidelines used by practitioners as indicators for prolotherapy
- Recurrent swelling or fullness involving a joint or muscular region
- Popping, clicking, grinding, or catching sensations with movement
- A sensation of the “leg giving way” with associated back pain
- Temporary benefit from chiropractic manipulation or manual mobilization that fails to ultimately resolve the pain
- Distinct tender points and “jump signs” along the bone at tendon or ligament attachments
- Numbness, tingling, aching, or burning, referred into an upper or lower extremity
- Recurrent headache, face pain, jaw pain, ear pain
- Chest pain with tenderness along the rib attachments on the spine or along the front of the chest
- Spine pain that does not respond to surgery, or whose origin is not clear or consistent based on extensive studies
Prolotherapy is sometimes used as an alternative to arthroscopic surgery.
Evidence based medicine
A Cochrane review of the medical literature as of January 2004 on the efficacy of prolotherapy injections in adults with chronic low-back pain[5] found four controlled trials, all measuring pain and disability levels at six months. The review concluded:
- "There is conflicting evidence regarding the efficacy of prolotherapy injections in reducing pain and disability in patients with chronic low-back pain. Conclusions are confounded by clinical heterogeneity amongst studies and by the presence of co-interventions. There was no evidence that prolotherapy injections alone were more effective than control injections alone. However, in the presence of co-interventions, prolotherapy injections were more effective than control injections, more so when both injections and co-interventions were controlled concurrently."
The review also noted: "[m]inor side effects from the treatment, such as increased back pain and stiffness, were common but short-lived." ("Stiffness" is an expected short-lived side effect, as the goal is to cause irritation and the corresponding body reaction of temporary inflammation and repair.)
More recently, Rabago et al. [A systematic review of prolotherapy for chronic musculoskeletal pain. Clin J Sport Med. 2005 Sep;15(5):376-80] noted: "Two [randomized controlled trials] on osteoarthritis reported decreased pain, increased range of motion, and increased patellofemoral cartilage thickness after prolotherapy."
Criticism
Most major medical insurance policies do not cover the treatment. After a 1999 review of the medical evidence, Medicare declined to cover prolotherapy for chronic low back pain citing that prolotherapy "was last examined for coverage by the Health Care Financing Administration (HCFA) in September 1992".[6]
Ongoing studies
Knee injuries
A randomized, double-blind, placebo control study is currently recruiting patients to determine whether prolotherapy can decrease pain and disability from knee osteoarthritis. This study is sponsored by the National Center for Complementary and Alternative Medicine (NCCAM).[7]
Tennis elbow
A randomized, double-blind, placebo control study is currently recruiting patients to determine whether prolotherapy can be an effective treatment for lateral epicondylitis (tennis elbow).[8]
Thumb Joint Arthritis
A randomized, double-blind, placebo control study is currently recruiting patients to compare prolotherapy to injection of corticosteroids in treating carpo-metacarpal joint arthritis of the thumb.[9]
Plantar Fasciitis
Sonographically guided dextrose injections showed a good clinical response in patients with chronic plantar fasciitis insofar as reducing pain during rest and activity. Further studies including a control group are needed to validate these outcomes.[10]
See also
References
Cite error: Invalid <references> tag;
parameter "group" is allowed only.
<references />, or <references group="..." />External links
- www.ACOPMS.com - The American Osteopathic Association of Prolotherapy Integrative Pain Management, affiliated with the American Osteopathic Association, is an association of licensed practitioners dedicated toward improving the practice of, and disseminating knowledge about Prolotherapy.
- Prolotherapy.org is a source for extensive articles, diagrams and other resources related to prolotherapy.
- Prolotherapy.com - a source for information on nonsurgical ligament reconstruction
- American Association of Orthopaedic Medicine is a non-profit organization that promotes prolotherapy.
- "CAM Prolotherapy Project". 2006-08-06. Retrieved 2006-08-06.
- Brody, Jane E. (2007-08-07). "Injections to Kick-Start Tissue Repair". New York Times. Retrieved 2008-07-24.es:Proloterapia
- ↑ Brody, Jane E. (2007-08-07). "Injections to Kick-Start Tissue Repair". New York Times. Retrieved 2008-07-24.
Prolotherapy involves a series of injections designed to produce inflammation in the injured tissue. To appreciate the value of such a seemingly counterproductive measure, you need to know something about connective tissue and how the body normally repairs it. When tissues are injured, inflammation is a common natural response. It stimulates substances carried in blood that produce growth factors in the injured area to promote healing. Ligaments, tendons and cartilage have very poor blood supplies, which can result in incomplete healing.
- ↑ Mayo Clinic (2005). "Alternative treatments: Dealing with chronic pain". Mayo Clinic Health Letter. 23 (4).
- ↑ Hauser, Ross. "The History of Prolotherapy". Retrieved 2007-08-26.
In 1955, at an American Medical Association meeting, Dr. Hemwall was astonished to see so many doctors at one particular exhibit. The presenter was talking about a very successful treatment for chronic low back pain. Nothing was worse at the time for Dr. Hemwall than having a chronic low back pain patient come to him, because the treatments he was able to offer were not very successful. The doctor doing the presentation was George S. Hackett, M.D., and he was discussing the technique of Prolotherapy. Once the crowd diminished, Dr. Hemwall asked Dr. Hackett how he could learn the treatment described in his book, Ligament and Tendon Relaxation Treated by Prolotherapy. Dr. Hemwall went to Dr. Hackett's office in Canton, Ohio, to learn the technique. Dr. Hemwall became so proficient at administering the technique that Dr. Hackett would later refer patients to him. Prolotherapy owes a great debt to Dr. Hemwall. Between 1955 until his retirement in 1996, he was the main instructor and proponent of Prolotherapy in the United States. He was not a researcher but a clinician, and perhaps the world's greatest Prolotherapist. He treated more than 10,000 patients world wide and collected data on 8,000 of these patients. In 1974, Dr. Hemwall presented his largest survey of 2,007 Prolotherapy patients to the Prolotherapy Association.
- ↑ 4.0 4.1 Banks, Alan. "A Rationale for Prolotherapy".
Prolotherapy, the technology for strengthening lax ligaments, has found increased acceptance in recent years. However, despite its greater use, the mechanism of action of prolotherapy is not well understood. In the past few years a number of advances have been made in the understanding of wound repair. This author believes the increased knowledge which has been made available in the field of wound healing has application to a more complete understanding of prolotherapy. There follows a general discussion of wound healing and a hypothesis which provides a basis for understanding prolotherapy.
- ↑ Dagenais, S.; Yelland, M.; Del Mar, C.; Schoene, M.; Dagenais, S. (2007). "Prolotherapy injections for chronic low-back pain". Cochrane database of systematic reviews (Online) (2): CD004059. doi:10.1002/14651858.CD004059.pub3. PMID 17443537.[1] Cochrane collaboration
- ↑ "HCFA Decision Memorandum". Quackwatch. Retrieved 2008-07-24.
- ↑ [2] Clinicaltrials.Gov, Joint Injections for Osteoarthritic Knee Pain, web page last updated October 16, 2006
- ↑ http://clinicaltrials.gov/ct2/show?cond=%22Tennis+Elbow%22&rank=3 Clinicaltrials.Gov, Efficacy Study of Prolotherapy vs Corticosteroid for Tennis Elbow
- ↑ Prolotherapy Versus Steroids for Thumb Carpo-Metacarpal Joint Arthritis
- ↑ Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
